Glomeria Therapeutics

About:

Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area.

Website: http://www.glomeria.com/en/

Twitter/X: GlomeriaSrl

Top Investors: Green Arrow Capital, EASME - EU Executive Agency for SMEs, Vertis, Sofimac Investment Managers, Spindial Group

Description:

Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis. Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.